Igor Aurer

2.3k total citations
88 papers, 950 citations indexed

About

Igor Aurer is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Igor Aurer has authored 88 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pathology and Forensic Medicine, 38 papers in Oncology and 33 papers in Genetics. Recurrent topics in Igor Aurer's work include Lymphoma Diagnosis and Treatment (60 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Viral-associated cancers and disorders (17 papers). Igor Aurer is often cited by papers focused on Lymphoma Diagnosis and Treatment (60 papers), Chronic Lymphocytic Leukemia Research (26 papers) and Viral-associated cancers and disorders (17 papers). Igor Aurer collaborates with scholars based in Croatia, Netherlands and Italy. Igor Aurer's co-authors include Boris Labar, Ivo Radman, Mirando Mršić, R P Gale, Dubravka Sertić, Zdravko Mitrović, Sandra Bašić‐Kinda, Jasminka Jakić‐Razumović, Dan Nemet and Anna Sureda and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Igor Aurer

75 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Igor Aurer Croatia	20	531	449	223	187	170	88	950
Gregory Bociek United States	14	562 1.1×	379 0.8×	230 1.0×	174 0.9×	129 0.8×	35	836
Alessia Bari Italy	19	550 1.0×	449 1.0×	179 0.8×	119 0.6×	179 1.1×	53	911
Biljana Mihaljević Serbia	15	687 1.3×	417 0.9×	289 1.3×	115 0.6×	157 0.9×	103	1.1k
Astrid Franke Germany	13	641 1.2×	403 0.9×	392 1.8×	154 0.8×	141 0.8×	28	1.0k
Geoffrey Chong Australia	15	307 0.6×	393 0.9×	179 0.8×	117 0.6×	95 0.6×	59	769
Mars B. van ’t Veer Netherlands	15	536 1.0×	356 0.8×	284 1.3×	198 1.1×	292 1.7×	36	1.4k
M. Jesús Nambo Mexico	17	544 1.0×	451 1.0×	119 0.5×	139 0.7×	90 0.5×	42	896
Ilse Christiansen Denmark	14	438 0.8×	227 0.5×	229 1.0×	148 0.8×	152 0.9×	31	789
J. M. Vose United States	15	801 1.5×	596 1.3×	289 1.3×	115 0.6×	243 1.4×	34	1.2k
Flavia Salvi Italy	18	948 1.8×	477 1.1×	257 1.2×	203 1.1×	177 1.0×	50	1.2k

Countries citing papers authored by Igor Aurer

Since Specialization

Citations

This map shows the geographic impact of Igor Aurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Aurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Aurer more than expected).

Fields of papers citing papers by Igor Aurer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Aurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Aurer. The network helps show where Igor Aurer may publish in the future.

Co-authorship network of co-authors of Igor Aurer

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Aurer. A scholar is included among the top collaborators of Igor Aurer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Aurer. Igor Aurer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jerkeman, Mats, Igor Aurer, Elı́as Campo, et al.. (2025). EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma. HemaSphere. 9(10). e70233–e70233.

Aurer, Igor, Ozren Jakšić, Sandra Bašić‐Kinda, et al.. (2024). Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases. Biomedicines. 12(2). 331–331. 1 indexed citations

Mitrović, Zdravko, et al.. (2023). Dose‐adjusted EPOCH and rituximab (DA‐EPOCH‐R) in older patients with high‐risk aggressive diffuse large B‐cell lymphoma: A real‐life multicenter study by the Croatian Cooperative Group for Hematologic diseases (KroHem). European Journal Of Haematology. 110(6). 725–731.

Premužić, Vedran, et al.. (2023). Glomerular filtration rate is an independent prognostic factor in patients with B-large cell lymphoma. Medicine. 102(20). e33675–e33675.

Mrđenović, Stefan, et al.. (2022). Clinical Dilemmas in the Treatment of Elderly Patients Suffering from Hodgkin Lymphoma: A Review. Biomedicines. 10(11). 2917–2917. 1 indexed citations

Bašić‐Kinda, Sandra, et al.. (2021). Improvement in the outcomes of mantle cell lymphoma in the last decade: a real-life non interventional study of the Croatian Cooperative Group for Hematologic Diseases. Croatian Medical Journal. 62(5). 455–463. 2 indexed citations

Bašić‐Kinda, Sandra, et al.. (2020). R-CHOEP14 in younger high-risk patients with large B cell lymphoma: an effective front-line regimen with cardiac toxicity: a real-life, single-center experience. Annals of Hematology. 100(6). 1517–1524. 5 indexed citations

Radman, Ivo, Jelena Roganović, Duška Petranović, et al.. (2019). Croatian Hematology Society and CROHEM guidelines for the treatment of iron deficiency anemia. Hrčak Portal of scientific journals of Croatia (University Computing Centre). 141(1-2). 1–13. 2 indexed citations

Sharman, Jeff P., Anna Marina Liberati, Kenichi Ishizawa, et al.. (2019). A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera®) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL). BioDrugs. 34(2). 171–181. 35 indexed citations

10.

Aurer, Igor, et al.. (2019). PF322 APPROACH TO DOUBLE HIT LYMPHOMA (DHL) DIAGNOSIS AND TREATMENT IN EUROPE – A CROSS‐SECTION STUDY OF EHA LYMPHOMA WORKING PARTY (EHA LYG). HemaSphere. 3(S1). 113–114. 1 indexed citations

11.

Krečak, Ivan, Sandra Bašić‐Kinda, Ivana Lapić, et al.. (2018). Serum chitotriosidase: a circulating biomarker in polycythemia vera. Hematology. 23(10). 793–802. 4 indexed citations

12.

Dreyling, Martin, Igor Aurer, Sergio Cortelazzo, et al.. (2017). Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations. Leukemia & lymphoma. 59(8). 1814–1828. 18 indexed citations

13.

Krznarić, Željko, et al.. (2012). Epstein-Barr Virus-Negative Aggressive Natural Killer-Cell Leukaemia with High P-Glycoprotein Activity and Phosphorylated Extracellular Signal-Regulated Protein Kinases 1 and 2. SHILAP Revista de lepidopterología. 4(3). e16–e16. 4 indexed citations

14.

Paar, Maja Hrabak, et al.. (2010). (Mis)placed central venous catheter in the left superior intercostal vein. Radiology and Oncology. 45(1). 27–30. 9 indexed citations

15.

Mitrović, Zdravko, Ivana Ilić, Marin Nola, et al.. (2009). CD43 Expression Is an Adverse Prognostic Factor in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma & Myeloma. 9(2). 133–137. 19 indexed citations

16.

Mršić, Mirando, Boris Labar, Nadira Duraković, et al.. (2009). Dvadeset godina liječenja teške aplastične anemije u Zavodu za hematologiju Klinike za unutrašnje bolesti Kliničkog bolničkog centra Zagreb. 63. 209–214. 1 indexed citations

17.

Bulum, Joško, et al.. (2007). Primary cardiac lymphoma presenting as atrial flutter and total heart block. Heart and Vessels. 22(1). 52–54. 19 indexed citations

18.

Dai, Hui, Ivo Radman, Boris Labar, et al.. (2006). The Value of F-18 FDG Triple-Head Coincidence PET in the Posttreatment Evaluation of Patients With Lymphoma. Clinical Nuclear Medicine. 31(5). 275–278. 2 indexed citations

19.

Nemet, Damir, Ivo Radman, Igor Aurer, et al.. (2003). High-Dose Ifosfamide and Mitoxantrone (HDIM) as Cytoreductive and Mobilisation Protocol for Relapsed and Refractory Lymphoma. Blood. 1 indexed citations

20.

Sučić, Mirna, Renata Zadro, Boris Labar, et al.. (2002). Acute Promyelocytic Leukemia M3: Cytomorphologic, Immunophenotypic, Cytogenetic, and Molecular Variants. Journal of Hematotherapy & Stem Cell Research. 11(6). 941–950. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact